Skip to main content
University of Washington Health Sciences Library

CI # 51551 How effective are ACE inhibitors and ARBs for the prevention of migraines?: search

Search Summary

Cochrane Library - CDSR (Systematic Reviews)

0

angiotensin and (headache OR migraine)

angiotensin and migraine* (Trials)

Cochrane Library - Other Systematic Reviews (DARE) 0 same strategy used as for CDSR above
PubMed

Systematic reviews & meta analyses

4 (migraine disorders/pc[mh] OR migraine disorders/dt[mh] OR (migraine*[tw] AND (prevent*[tw] OR protect*[tw] OR prophylaxis[tw] OR prophylactic*[tw] OR pharmacologic treatment*[tw] OR pharmacologic therap*[tw] OR drug therapy[tw]))) AND (angiotensin OR ace inhibitor*) AND (Meta Analysis[pt] OR meta analy*[ti] OR metaanaly*[ti] OR systematic review*[ti] OR data synthesis[tw] OR data extraction[tw] OR Cochrane Database Syst Rev[ta])
PubMed

RCTs

9 (migraine disorders/pc[mh] OR migraine disorders/dt[mh] OR (migraine*[tw] AND (prevent*[tw] OR protect*[tw] OR prophylaxis[tw] OR prophylactic*[tw] OR pharmacologic treatment*[tw] OR pharmacologic therap*[tw] OR drug therapy[tw]))) AND (angiotensin OR ace inhibitor*) AND (randomized controlled trial[pt] OR ((random*[tw] AND trial*[tw]) NOT medline[sb])) NOT (Meta Analysis[pt] OR meta analy*[ti] OR metaanaly*[ti] OR systematic review*[ti] OR data synthesis[tw] OR data extraction[tw] OR Cochrane Database Syst Rev[ta])
Cochrane Library - Clinical Trials 3

additional RCTs not in PubMed results:

Javanmard SH, Sonbolestan SA, Heshmat K. The effect of enalapril on anti-inflammatory cytokines in patients with migraine: A double-blind, randomized clinical trial. Journal of Isfahan Medical School. 2013;31:232.

Brainerd JB. Angiotensin and aldosterone elevation in salt-induced migraine. Headache. 1981; 21(5):222-6.

Park HJ, Lee ST, Kim M. Inhibitory control of angiotensin-converting enzyme by ramipril in migraine. Neurology Asia. 2013; 18(3):289-91.

 

 

PubMed

other clinical trials; duplicates removed

27 (migraine disorders/pc[mh] OR migraine disorders/dt[mh] OR (migraine*[tw] AND (prevent*[tw] OR protect*[tw] OR prophylaxis[tw] OR prophylactic*[tw] OR pharmacologic treatment*[tw] OR pharmacologic therap*[tw] OR drug therapy[tw]))) AND (angiotensin OR ace inhibitor*) AND (Clinical Trial[pt] OR Multicenter Study[pt] OR trial[tw] OR trials[tw] OR multicenter[tw] OR multicentre[tw] OR multi center[tw] OR multi centre[tw] OR placebo*[tw] OR double blind*[tw] OR Treatment Outcome[mh] OR outcome*[tw] OR evidence based[tw]) NOT (randomized controlled trial[pt] OR ((random*[tw] AND trial*[tw]) NOT medline[sb]) OR Meta Analysis[pt] OR meta analy*[ti] OR metaanaly*[ti] OR systematic review*[ti] OR data synthesis[tw] OR data extraction[tw] OR Cochrane Database Syst Rev[ta] OR Guideline[pt] OR Practice Guideline[pt] OR Consensus Development Conference[pt] OR Consensus Development Conference, NIH[pt] OR practice guidelines as topic[mh] OR consensus[ti] OR guideline*[ti] OR guidance[ti])
PubMed

Guidelines; duplicates removed

5

(migraine disorders/pc[mh] OR migraine disorders/dt[mh] OR (migraine*[tw] AND (prevent*[tw] OR protect*[tw] OR prophylaxis[tw] OR prophylactic*[tw] OR pharmacologic treatment*[tw] OR pharmacologic therap*[tw] OR drug therapy[tw]))) AND (angiotensin OR ace inhibitor*) AND (Guideline[pt] OR Practice Guideline[pt] OR Consensus Development Conference[pt] OR Consensus Development Conference, NIH[pt] OR practice guidelines as topic[mh] OR ((consensus[ti] OR guideline*[ti] OR guidance[ti]) NOT medline[sb]))

 

National Guideline Clearinghouse

AHRQ

2

 

2

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. 2000 Sep, Revised 2012 Apr 24.

 

Canadian Headache Society guideline for migraine prophylaxis. 2012 Mar.

Migraine in adults: preventive pharmacologic treatments. 2013 Apr. Report No.: 13-EHC068-EF. AHRQ Comparative Effectiveness Reviews.

Preventive pharmacological treatments for migraine in adults: future research needs: identification of future research needs from comparative effectiveness. Review No. 103. 2013 Apr. Report No.: 13-EHC046-EF. AHRQ Future Research Needs Papers.

FPIN CIs, PURLS, HDAs 1 What is the most effective prophylactic medication for migraine headaches? Evidence-Based Practice 19, no. 6 (2016): 6-7

Author Information

Clinician Authors: Brendan Morris and Jon Neher

Librarian:  Sarah Safranek

Search Due Date: Nov 2016

Manuscript Due Date:

Contact and Questions

Ordering Articles/Books

Librarian Contact Information:

Sarah Safranek, MLIS
Information Management Librarian
safranek@uw.edu
guides.lib.uw.edu/hsl/safranek

Health Sciences Library | 1959 NE Pacific Street, T334 Health Sciences Building, Box 357155, Seattle, WA 98195-7155 USA, 206-543-3390 | Privacy | Terms